Pirodomast

CAS No. 108310-20-9

Pirodomast( —— )

Catalog No. M36113 CAS No. 108310-20-9

Pirodomast is a thromboxane A (TXA2) synthase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 246 Get Quote
5MG 371 Get Quote
10MG 561 Get Quote
25MG 868 Get Quote
50MG 1178 Get Quote
100MG 1557 Get Quote
500MG 3114 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pirodomast
  • Note
    Research use only, not for human use.
  • Brief Description
    Pirodomast is a thromboxane A (TXA2) synthase inhibitor.
  • Description
    Pirodomast is a thromboxane A (TXA2) synthase inhibitor. Pirodomast inhibits leukotriene (LT) D4, C4, E4 formation and thromboxane B2 (TXB2) activity, but is weakly or ineffectively antagonistic to guinea pig bronchospasm induced by histamine, methacholine, serotonin, LTC4, or platelet-activating factor. Pirodomast is a potential antiallergic compound. Pirodomast had only weak relaxant activity on guinea pig trachea in vitro. Pirodomast is a potential antiallergic compound that inhibits the protein hydrolyzing activity of trypsin in vitro, prevents antigen-induced immediate and late asthmatic responses in allergic sheep in vivo, and inhibits antigen-induced airway hyperresponsiveness to histamine and carbachol in allergic sheep.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thrombin | Serine Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    108310-20-9
  • Formula Weight
    307.35
  • Molecular Formula
    C18H17N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C=2C(C(=O)C1N3CCCC3)=CC=CN2)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Enoxaparin sodium

    Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).

  • Dabigatran etexilate

    A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.

  • Dabigatran etexilate...

    A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.